Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.11.23
/
50%
€22.25
Target price
13.11.24
€65.39
Performance (%)
-26.34%
Price
04.10.24
€16.39
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -26.34%. This prediction currently runs until 13.11.24. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -12.912% | -12.912% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat